Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
40 IU Intranasal Oxytocin
DRUG
2 trials
Sponsors
Icahn School of Medicine at Mount Sinai
, Medical University of South Carolina
Conditions
Alcohol Use Disorder
Borderline Personality Disorder
PTSD
Phase 2
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
Completed
NCT04523922
Medical University of South Carolina
Alcohol Use Disorder, PTSD
Start: 2021-03-29
End: 2026-04-13
Updated: 2026-07-27
Unknown Phase
The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults
Suspended
NCT02225600
Icahn School of Medicine at Mount Sinai
Borderline Personality Disorder
Start: 2014-08-26
End: 2027-12-01
Target: 40
Updated: 2026-07-02
Related Papers
COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans.
2023-01-13
5 citations